Longevity medicine moves into the hospital - academic systems open clinics
18th October 2026
Since last fall, Cedars-Sinai, Northwestern Medicine and Weill Cornell Medicine have launched longevity medicine programs aimed at extending healthspan - the years lived without chronic disease or disability - and Mount Sinai expects to open its program this month. The academic systems are betting that their research ties set them apart from the hundreds of private US longevity clinics, some charging thousands to tens of thousands of dollars a year for screenings and therapies not yet proven effective: Northwestern’s clinic, for example, draws partly on the university’s Potocsnak Longevity Institute, which is studying biomarkers of aging.
Key takeaways:
- The evidence line differs inside academia itself: Northwestern does not offer whole-body MRI, citing a lack of evidence that it lengthens lifespan, nor genome sequencing, while Mount Sinai will offer both after patients review the risks and benefits with their physician
- Price still gates access, because insurers cover few longevity services: Northwestern charges $5,500 a year, Weill Cornell charges $7,500 for a one-time assessment and $12,000 for a program with quarterly visits, and Cedars-Sinai covers its core evaluation through insurance with other assessments offered through research trials
- Northwestern medical director Baljash Cheema told the Times the system knows it is losing market share among patients with financial means who want that testing, but has “a pretty strong line in the sand about it”
Hype check: Proven - the launches, the Mount Sinai opening plan and the stated prices and testing policies as reported. Promising - that research-linked academic programs will produce better outcomes than private clinics; no outcome data is offered yet. Marketing - any academic branding that implies proven lifespan extension; the systems themselves disagree on what is proven.